Elasmogen is a precision biologics drug discovery company that develops soloMERs.
Elasmogen has raised €2.3M across 1 funding round from 1 investor, most recently a round in Oct 2020. Based in Aberdeen, UK; founded 2016; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2020-10-01 | Other | €2.3M |
| Deepbridge Capital |
| View deal → |
